In USA, Michigan AG uncovers significant disparities in drug prices

27 February 2006

US state of Michigan Attorney General Mike Cox has announced the results of an undercover investigation his office conducted regarding the price of medicines across the state, which uncovered significant variations in the cost of prescription drugs.

The Attorney General called on the Department of Community Health and the Governor to take the drug price information that they have now for pharmacies across Michigan and make it available on a user-friendly drug price web site, listing all drugs that are prescribed, in communities across the state, with regular monthly updates on price changes. He also announced investigations of 17 pharmacies for price gouging.

In addition, AG Cox said that his office is notifying more than two dozen pharmacies of alleged illegal conduct in refusing to provide drug price information over the phone, as required by law.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight